Table 3 Selected antimicrobial susceptibility patterns from the main bacteria of septic neonates, 2011 to 2017
Antibiotics | No. (%) susceptible | ||
|---|---|---|---|
Coagulase-negative staphylococci (n = 34) | Escherichia coli (n = 58) a | Klebsiella pneumoniae (n = 39) | |
Amoxicillin | 11 (32.4) | – | – |
Amikacin | – | 58 (100) | 39 (100) |
Ampicillin | 11 (32.4) | 13 (22.4) | 4 (10.3) |
Cefazolin | 13 (38.2) | 26 (44.8) | 5 (12.8) |
Ceftazidime | 22 (64.7) | 49 (84.5) | 11 (28.2) |
Cefoperazone/sulbactam | 24 (70.6) | 58 (100) | 39 (100) |
Furadantin | 34 (100) | 58 (100) | 23 (59.0) |
Imipenem | – | 58 (100) | 39 (100) |
Ciprofloxacin | 27 (79.4) | 25 (43.1) | 33 (84.6) |
Nitrofurantoin | 34 (100) | 58 (100) | 24 (61.6) |
Piperacillin/tazobactam | – | 58 (100) | 39 (100) |
Sulfamethoxazole-trimethoprim | 17 (50.0) | 19 (32.8) | 26 (66.7) |
Vancomycin | 34 (100) | – | – |